Charles Schwab Investment Management Inc Annexon, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Annexon, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 743,795 shares of ANNX stock, worth $1.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
743,795
Previous 732,216
1.58%
Holding current value
$1.7 Million
Previous $4.33 Million
11.98%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding ANNX
# of Institutions
155Shares Held
98MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$17 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$16 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$15.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$14.4 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$12.9 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $109M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...